FCMTX | FRCTX | FCMTX / FRCTX | |
Total Expense Ratio | 0.67 | 1.16 | 58% |
Annual Report Gross Expense Ratio | 0.67 | 1.16 | 58% |
Fund Existence | 23 years | 30 years | - |
Gain YTD | -1.856 | -3.107 | 60% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.68B | 12.4B | 14% |
Annual Yield % from dividends | 2.66 | 3.16 | 84% |
Returns for 1 year | 1.11 | -0.39 | -287% |
Returns for 3 years | 6.93 | 2.40 | 289% |
Returns for 5 years | 1.32 | -5.24 | -25% |
Returns for 10 years | 17.65 | -0.64 | -2,739% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WVCCX | 32.94 | 0.06 | +0.18% |
abrdn International Small Cp A | |||
FPHAX | 23.37 | N/A | N/A |
Fidelity Select Pharmaceuticals Port | |||
SPINX | 19.77 | N/A | N/A |
SEI S&P 500 Index A (SIIT) | |||
FAFGX | 75.28 | -0.53 | -0.70% |
American Funds Growth Fund of Amer 529F2 | |||
BRWVX | 24.43 | -0.24 | -0.97% |
MFS Blended Research Growth Eq R6 |